Table 4.
Gametocyte prevalence rate at enrollment and gametocyte carriage rate (overall and among children without gametocytemia at enrollment)
2005 | 2008 | 2009 | 2010 | |
---|---|---|---|---|
Total number of patients | 210 | 206 | 285 | 110 |
Prevalence (%) | 17 (8.1%) | 4 (1.9%) | 9 (3.2%) | 4 (3.6%) |
Overall gametocyte carriage rate | ||||
Person-weeks of follow-up | 1,050 | 1,236 | 1,710 | 550 |
Gametocyte carriage (in weeks) | 14 | 0.4 | 1.7 | 1.2 |
Gametocyte carriage rate (per 1,000 PGW) | 13 | 0.3 | 1 | 2 |
Patients without gametocyte at enrollment | ||||
Person-weeks of follow-up | 30 | 18 | 12 | – |
Gametocyte carriage (in weeks) | 1.4 | 0.8 | 0.5 | – |
Gametocyte carriage rate (per 1,000 PGW) | 46 | 44 | 42 | |
Gametocytemia at enrollment | ||||
Total number of patients | ||||
AA | 120 | 104 | 204 | 58 |
AL | 90 | 102 | 81 | 52 |
Prevalence (%) | ||||
AA | 11 (9.1%) | 4 (3.8%) | 6 (2.9%) | 1 (1.7%) |
AL | 6 (6.7%) | 0 | 2 (2.5%) | 3 (5.8%) |